MARKETSZydus Shares Slip Even as USFDA Clears Phase III TrialTabassum ChaudharyJuly 23, 2026July 23, 2026 July 23, 2026July 23, 2026 Zydus Lifesciences shares slipped 2% on the NSE on Thursday, even after the company cleared a big regulatory hurdle for a new drug trial. The...